| Patent | Date |
|---|
Monoclonal antibodies with enhanced ADCC function
Grant 10,081,683 - Beliard , et al. September 25, 2 | 2018-09-25 |
Use of ADCC-optimized antibodies for treating low-responder patients
Grant 9,879,089 - Bourel , et al. January 30, 2 | 2018-01-30 |
Monoclonal Antibodies With Enhanced Adcc Function
App 20180002442 - BELIARD; ROLAND ; et al. | 2018-01-04 |
Monoclonal antibodies with enhanced ADCC function
Grant 9,718,890 - Beliard , et al. August 1, 2 | 2017-08-01 |
Monoclonal antibodies with enhanced ADCC function
Grant 9,718,889 - Beliard , et al. August 1, 2 | 2017-08-01 |
Monoclonal antibodies with enhanced ADCC function
Grant 9,708,409 - Beliard , et al. July 18, 2 | 2017-07-18 |
Use Of Adcc-optimized Antibodies For Treating Weak Patients
App 20150307624 - Bourel; Dominique ; et al. | 2015-10-29 |
Monoclonal Antibodies With Enhanced Adcc Function
App 20150266972 - BELIARD; Roland ; et al. | 2015-09-24 |
Use of ADCC-optimized antibodies for treating weak patients
Grant 9,109,020 - Bourel , et al. August 18, 2 | 2015-08-18 |
Monoclonal Antibodies With Enhanced Adcc Function
App 20150152189 - Beliard; Roland ; et al. | 2015-06-04 |
Monoclonal Antibodies With Enhanced Adcc Function
App 20140162356 - Beliard; Roland ; et al. | 2014-06-12 |
Monoclonal antibodies with enhanced ADCC function
Grant 8,685,725 - Beliard , et al. April 1, 2 | 2014-04-01 |
Use Of Adcc-optimized Antibodies For Treating Weak Patients
App 20140017243 - Bourel; Dominique ; et al. | 2014-01-16 |
Use of ADCC-optimized antibodies for treating weak patients
Grant 8,501,171 - Bourel , et al. August 6, 2 | 2013-08-06 |
Monoclonal antibodies with enhanced ADCC function
Grant 8,409,572 - Beliard , et al. April 2, 2 | 2013-04-02 |
Anti-D monoclonal antibodies
Grant 8,357,370 - Beliard , et al. January 22, 2 | 2013-01-22 |
Monoclonal Antibodies With Enhanced Adcc Function
App 20120259095 - Beliard; Roland ; et al. | 2012-10-11 |
Anti-d Monoclonal Antibodies
App 20120258096 - Beliard; Roland ; et al. | 2012-10-11 |
Method for treating infectious disease using monoclonal antibodies
Grant 8,178,093 - Beliard , et al. May 15, 2 | 2012-05-15 |
Method for treating cancer using monoclonal antibodies
Grant 8,153,124 - Beliard , et al. April 10, 2 | 2012-04-10 |
Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodies
Grant 8,124,078 - Beliard , et al. February 28, 2 | 2012-02-28 |
Monoclonal Antibodies With Enhanced Adcc Function
App 20110223658 - Beliard; Roland ; et al. | 2011-09-15 |
Monoclonal antibodies with enhanced ADCC function
Grant 7,931,895 - Beliard , et al. April 26, 2 | 2011-04-26 |
Method For Treating Cancer Using Monoclonal Antibodies
App 20110059072 - Beliard; Roland ; et al. | 2011-03-10 |
Method For Treating Infectious Disease Using Monoclonal Antibodies
App 20110059073 - BELIARD; ROLAND ; et al. | 2011-03-10 |
Method For Treating Idiopathic Thrombocytopenic Purpura Using Monoclonal Antibodies
App 20110052571 - Beliard; Roland ; et al. | 2011-03-03 |
Cytokine production-inducing antibody
App 20100323368 - de Romeuf; Christophe ; et al. | 2010-12-23 |
Use of ADCC-Optimized antibodies for treating weak patients
App 20100303826 - Bourel; Dominique ; et al. | 2010-12-02 |
Preparation of human, humanized or chimaeric antibodies or polypeptides having different binding profiles to Fcgamma receptors
Grant 7,790,399 - Bourel , et al. September 7, 2 | 2010-09-07 |
Antibody for ADCC And Inducing Cytokine Production
App 20100145026 - de ROMEUF; Christophe ; et al. | 2010-06-10 |
Use of ADCC-optimized antibodies for treating low-responder patients
Grant 7,713,524 - Bourel , et al. May 11, 2 | 2010-05-11 |
Method of measuring activation of effector cells
Grant 7,595,165 - Romeuf , et al. September 29, 2 | 2009-09-29 |
Method for preparing monoclonal antibodies capable of activating effector cells expressing FC.gamma.RIII
Grant 7,579,170 - Beliard , et al. August 25, 2 | 2009-08-25 |
Anti-rhesus D monoclonal antibodies
Grant 7,541,029 - Beliard , et al. June 2, 2 | 2009-06-02 |
Treatment Of Pathologies Which Escape The Immune Response, Using Optimized Antibodies
App 20090081216 - de ROMEUF; Christophe ; et al. | 2009-03-26 |
Novel lgG3 Antibodies for Stimulating Phagocytosis
App 20070218052 - Romeuf; Christophe De ; et al. | 2007-09-20 |
Therapeutic products with enhance ability to immunomodulate cell functions
App 20070135621 - Bourel; Dominique ; et al. | 2007-06-14 |
Correlation between the fucose content/galactose content ratio of anti-rhesus-d and anti-hla-dr antibodies and the adcc activity
App 20070015239 - Bihoreau; Nicolas ; et al. | 2007-01-18 |
Anti-Rhesus D monoclonal antibodies
App 20070009522 - Beliard; Roland ; et al. | 2007-01-11 |
Use of adcc-optimized antibodies for treating weak patients
App 20060182741 - Bourel; Dominique ; et al. | 2006-08-17 |
Antibody for adcc and inducing cytokine production
App 20060127392 - de Romeuf; Christophe ; et al. | 2006-06-15 |
Treatment of pathologies which escape the immune response, using optimised antibodies
App 20050271652 - de Romeuf, Christophe ; et al. | 2005-12-08 |
Monoclonal antibodies with enhanced ADCC function
App 20050249722 - Beliard, Roland ; et al. | 2005-11-10 |
Cytokine production-inducing antibody
App 20050249732 - de Romeuf, Christophe ; et al. | 2005-11-10 |
Ig fractions having immunomodulatory activity
Grant 6,932,969 - Bourel , et al. August 23, 2 | 2005-08-23 |
Antibody stimulating il-ira production
App 20050089520 - Bourel, Dominique ; et al. | 2005-04-28 |
Anti-rhesus d monoclonal antibodies
App 20030175969 - Beliard, Roland ; et al. | 2003-09-18 |
| 